Shanghai Chuangshi Medical Technology (Group) Co., Ltd.
FDA inspection history in Qingpu, China, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Qingpu, China.
Cited most
Across all Shanghai Chuangshi Medical Technology (Group) Co. observations on file
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
The complete Shanghai Chuangshi Medical Technology (Group) Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Qingpu, China
One Form 483 · 2024 · 3 observations
Latest: Form 483, Sep 13, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-09-13 | 483 Form 483 | Qingpu, China | 3 | $99 |
Investigators on these documents
FEI number 3005023997 · most recent document Sep 13, 2024
About Shanghai Chuangshi Medical Technology (Group) Co., Ltd.
How many FDA Form 483s has Shanghai Chuangshi Medical Technology (Group) Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Shanghai Chuangshi Medical Technology (Group) Co., Ltd.; the most recent is dated Sep 13, 2024.
When was Shanghai Chuangshi Medical Technology (Group) Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shanghai Chuangshi Medical Technology (Group) Co., Ltd. is a Form 483 dated Sep 13, 2024, for the site in Qingpu, China.
What did FDA cite at Shanghai Chuangshi Medical Technology (Group) Co., Ltd.?
The regulations cited most in the observations on file for Shanghai Chuangshi Medical Technology (Group) Co., Ltd. are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.166 (Stability testing), 1 time; 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.